IOL Chemicals and Pharmaceuticals Ltd 2021 AR2
The report highlights the financial and operational performance of IOL Chemicals and Pharmaceuticals Limited for the fiscal year 2020-21. The company successfully set up Metformin manufacturing Unit-7 and Ibuprofen Derivatives manufacturing Unit-8, while increasing Ethyl Acetate capacity. On the sustainability front, the company implemented energy conservation measures, including power management systems and biomass fuel optimization, resulting in significant fuel and water savings. Additionally, the company spent INR 3.82 crore on Corporate Social Responsibility initiatives focusing on education, healthcare, and disaster relief.
Company: IOL Chemicals and Pharmaceuticals Ltd
Sector: Manufacturing
Country: India
Year: 2021
Type: AR2
Pages: 108
Back to company
IOL Chemicals and Pharmaceuticals Ltd
Annual Report
The report highlights the financial and operational performance of IOL Chemicals and Pharmaceuticals Limited for the fiscal year 2020-21. The company successfully set up Metformin manufacturing Unit-7 and Ibuprofen Derivatives manufacturing Unit-8, while increasing Ethyl Acetate capacity. On the sustainability front, the company implemented energy conservation measures, including power management systems and biomass fuel optimization, resulting in significant fuel and water savings. Additionally, the company spent INR 3.82 crore on Corporate Social Responsibility initiatives focusing on education, healthcare, and disaster relief.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2021
Reporting Period
Apr 1, 2020 - Mar 31, 2021
Fiscal Year
2021
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Materiality Assessment
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Employees